ClinicalTrials.gg
TerminatedNCT03664479Updated Sep 14, 2018

Assess the Safety and Efficacy of the 4 Channel NMES, Pilot Study

An interventional study of 4 channel Electrical Stimulation Device in Dysphagia, sponsored by Seoul National University Hospital. Terminated at 1 site in South Korea. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-09-14.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment

Why this study was terminated
collected data showed significant difference in two groups.
Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

This study is a pilot study to prepare clinical trials to evaluate the safety and effectiveness of 4-channel electric stimulation therapy devices as a newly developed function for the treatment of dysphagia disorders.

The purpose of this study is to investigate the difference in effect by the electric stimulation method and to obtain the values such as mean, standard deviation and so on, and to determine the number of subjects to be studied for clinical trials of validation permission in the future.

Read the detailed description
  • Design: Prospective study
  • Inclusion criteria of patient group: who has a dysphagia symptom and confirmed by video-fluoroscopic swallowing study(N=9)
  • Intervention: Participants are divided into two group and applied electrical stimulation by a "Synchronized Electrical Stimulation Device(SESD)" in different protocol
  • Main outcome measures: high-resolution manometry(HRM) parameters, videofluoroscopic parameters, EQ-5D (EuroQoL-5D) questionnaire
02

Conditions studied

  • Dysphagia

Keywords

  • stroke
  • cervical spinal cord injury
03

In context

Deglutition Disorders

723 studies on the registry are indexed under Deglutition Disorders; 219 are open to participants now.

This study's enrollment of 4 is below the median of 60 across 482 interventional studies indexed under Deglutition Disorders.

Browse Deglutition Disorders studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,897 studies on the registry; 273 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patient who do not belong to the criteria excluded for subjects aged 19 years or older
  • Patient who is confirmed to be dysphagia by videofluoroscopy
  • Patients who need clinical application of electrical stimulation therapy equipment for dysphagia. ex) stroke, cervical spinal cord injury
  • Those voluntarily agreeing to the clinical trial

Exclusion criteria

Exclusion Criteria:

  • Patient who refuse inspection, do not agree
  • Simple "Commend obey", first step is impossible
  • When instructions can not be executed due to dementia, psychiatric disorders, etc.
  • Dysphagia occurs due to respiratory failure, neck surgery, etc.,
  • Pregnant women and lactating women
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
4 participants (actual)

Study arms

  • Experimental
    classical electrical stimulation protocol

    * apply 4 channel electrical stimulation device with protocol 1. * It will simultaneously stimulate suprahyoid, thyrohyoid and sternothyroid m with 4 channel electrical stimulation device. * during apply the device, we evaluate the manometry and videofluoroscopic swallowing study for evaluation of deglutition function.

    Device: 4 channel Electrical Stimulation Device

  • Experimental
    revised sequential activation protocol

    * apply 4 channel electrical stimulation device with protocol 2 * Is a revised sequential activation protocol, it sequentially stimulate bilateral suprahyoid m (channel 1), pharyngeal constrictors (ch 2), thyrohyoid m (ch 3), sternothyroid m (ch 4) with 4 channel electrical stimulation device. * during apply the synchronized electrical stimulation device, we will evaluate the parameters same as group 1.

    Device: 4 channel Electrical Stimulation Device

Interventions

  • Device4 channel Electrical Stimulation Device

    electrical stimulation at muscles which related with deglutition

06

What researchers measure

Primary outcomes

  1. pressure change

    Time frame: baseline/ change from baseline when electrical stimulation applied(the object of this study is to know the temporary change of dysphagia when stimulating with 4ch NMES.)

  2. videofluoroscopic dysphagia scale

    total score 100 from 0, 100 is worst outcome

    Time frame: baseline/ change from baseline when electrical stimulation applied(the object of this study is to know the temporary change of dysphagia when stimulating with 4ch NMES.

07

Study locations

1 site
  • Seoul National University Bundang Hospital
    Seongnam-si, Gyeonggi-do 463-707, South Korea
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03664479
Responsible party
Ju Seok Ryu (associate professor, Seoul National University Hospital) — Principal investigator
First posted
Sep 10, 2018
Start date
Mar 1, 2018
Primary completion
Jun 1, 2018
Completion
Jun 1, 2018
Last update
Sep 14, 2018

Study contacts

Jusuk Ryu, M.D. PhD
study director · Seoul National University Bundang Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion